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ABSTRACT: The fluorescent compound Hoechst 33342 is a substrate for many multidrug resistance (MDR)
transporters and is widely used to characterize their transport activity. We have constructed mutants of
the adenosine triphosphate (ATP) binding cassette (ABC)-type MDR transporter LmrA of Lactococcus
lactis that are defective in ATP hydrolysis. These mutants and wild-type LmrA exhibited an atypical
behavior in the Hoechst 33342 transport assay. In membrane vesicles, Hoechst 33342 transport was shown
to be independent of the ATPase activity of LmrA, and it was not inhibited by orthovanadate but sensitive
to uncouplers that collapse the proton gradient and to N,N¢-dicyclohexylcarbodiimide, an inhibitor of the
F0F1-ATPase. In contrast, transport of Hoechst 33342 by the homologous, heterodimeric MDR transporter
LmrCD showed a normal ATP dependence and was insensitive to uncouplers of the proton gradient.
With intact cells, expression of LmrA resulted in an increased rate of Hoechst 33342 influx while LmrCD
caused a decrease in the rate of Hoechst 33342 influx. Cellular toxicity assays using a triple knockout
strain, i.e., L. lactis ¢lmrA ¢lmrCD, demonstrate that expression of LmrCD protects cells against the
growth inhibitory effects of Hoechst 33342, while in the presence of LmrA, cells are more susceptible to
Hoechst 33342. Our data demonstrate that the LmrA-mediated Hoechst 33342 transport in membrane
vesicles is influenced by the transmembrane pH gradient due to a pH-dependent partitioning of Hoechst
33342 into the membrane.
The bisbenzimide dye Hoechst 33342 is a cell membrane-
permeant DNA stain that exhibits a bright blue fluorescence
upon binding to DNA. In Hoechst 33342-stained murine
lymphocyte cells, it was observed that the fluorescence
intensity is not always related to DNA content (1). This led
to the suggestion that membranes may exhibit different
permeabilities for Hoechst 33342. Involvement of drug
resistance proteins followed from experiments with colchi-
cine-resistant Chinese hamster ovary cell lines (1). Cell lines
with an increased resistance to colchicine concomitantly
showed a decreased rate of uptake of the dye. At a later stage,
Hoechst 33342 was identified as a substrate for P-glycopro-
tein (P-gp)1 (2).
Hoechst 33342 not only is fluorescent when bound to DNA
but also exhibits an increased fluorescence when it partitions
into the hydrophobic environment of the lipid membrane.
Since Hoechst 33342 is essentially nonfluorescent in an
aqueous environment, (net) transport of the compound from
the membrane to the aqueous phase will result in a decrease
in fluorescence. This has been the basis of Hoechst 33342
transport assays performed with reconstituted proteolipo-
somes and membrane vesicles derived from cells. Transport
of Hoechst 33342 can be continuously monitored by the
changes in fluorescence.
The Hoechst 33342 transport assay was first used to show
transport activity by reconstituted P-gp (2) and with plasma
membrane vesicles derived from highly multidrug-resistant
cells that express high levels of P-gp (3-5). The assay has
been widely used for the analysis of bacterial multidrug
transporters, like BmrA from Bacillus subtilis (6), HorA from
Lactobacillus breVis (7), MdfA from Escherichia coli (8),
NorA from Staphylococcus aureus (9), and LmrP, LmrA,
and LmrCD from Lactococcus lactis (10-12). Likewise,
Hoechst 33342 can also be used for binding studies (13).
To study the self-association of the LmrA dimer and the
presumed cooperativity between the nucleotide binding
domains, LmrA mutants defective in ATPase activity have
been constructed. As expected, these mutations resulted in
an inactivation of ATPase activity. Remarkably, the ATPase
mutants of LmrA showed Hoechst 33342 transport. Here we
show that LmrA mediates transmembrane passage of Hoechst
33342 in a pH-dependent manner.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Growth Conditions. L.
lactis NZ9000 (¢lmrA), an lmrA deletion strain (14), and
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pNZ8048-derived plasmids that permit expression of wild-
type and mutant His-tagged LmrA and Strep-tagged LmrCD
proteins under control of the nisin system (NICE) (Table 1)
(15). Cells were grown in M17 medium (Difco) supple-
mented with 0.5% (w/v) glucose and 5 íg/mL chloram-
phenicol.
DNA Manipulation. General procedures for cloning and
DNA manipulation were performed essentially as described
by Sambrook et al. (16). For site-directed mutagenesis to
create the nucleotide binding site mutants G490A and E512Q
of LmrA, the following primers were used: 5¢-ggagt-
caaaatttctggtgcacaaagacaacg-3¢ (G490A-FWD), 5¢-cgttgtctttgt-
gcaccagaaattttgactcc-3¢ (G490A-REV), 5¢-ctaatgcttgatcaag-
caacagc-3¢ (E512Q-FWD), 5¢-gctgttgcttgatcaagcattag-3¢
(E512Q-REV), 5¢-gattttgcttacgatgattctgaacaaatattgc-3¢ [“up-
stream” primer (EcoRV)], and 5¢-ggttttctaattttggttcaaa-
gaaagcttgagc-3¢ [“downstream” primer (XbaI)]. The PCR
overlap extension method (17) was used to introduce the
G490A (codon gca instead of gga on the DNA level) and
E512Q (codon caa instead of gaa on the DNA level)
mutations into the lmrA gene on the expression plasmid
pNHLmrA, yielding pHLA490A and pHLA512Q, respec-
tively (Table 1).
Preparation of Inside-Out Membrane Vesicles. Inside-out
membrane vesicles were prepared from L. lactis NZ9000
¢lmrA cells harboring pNZ8048-based expression or control
vectors. Cells were grown at 30 °Ct oa nO D 660 of 0.6-0.8,
whereupon 0.5 ng/mL Nisin A was added. Growth was
continued for a further 90 min. Cells were harvested by
centrifugation, washed with 100 mM Hepes-KOH (pH 7.0),
and resuspended in the same buffer. Inside-out membrane
vesicles were prepared by French pressure cell treatment as
described previously (11). Membrane vesicles suspended in
100 mM Hepes-KOH (pH 7.0) containing 10% (v/v) glycerol
were stored at -80 °C until they were used.
DCCD Treatment of Membrane Vesicles. To inactivate the
F0F1-ATPase, membranes (10 mg/mL total protein) were
incubated for 30 min with 10 mM N,N¢-dicyclohexylcarbo-
diimide (DCCD) on ice. Membrane vesicles were collected
by centrifugation, resuspended in 50 mM Hepes-KOH (pH
7.0) containing 10% (v/v) glycerol, and stored at -80 °C.
Purification of His6-LmrA. Membranes (10-20 mg/mL
total protein) bearing overexpressed histidine-tagged wild-
type or mutant LmrA were solubilized in 50 mM Hepes-
KOH (pH 8.0) containing 0.3 M NaCl, 10% (v/v) glycerol,
and 1% (w/v) n-dodecyl â-D-maltoside (DDM). The suspen-
sion was mixed and incubated on ice for 30 min. Insoluble
material was removed by centrifugation at 280000g (20 min
at 4 °C). Solubilized membrane proteins were mixed with
Ni2+-NTA agarose (Qiagen, 25 íL of resin/mg of protein)
which was pre-equilibrated in buffer A [50 mM Hepes-KOH
(pH 8.0), 0.3 M NaCl, 10% (v/v) glycerol, and 0.05% (w/v)
DDM] containing 20 mM imidazole. The suspension was
incubated for1ha t4°C, transferred to a Bio-spin column
(Bio-Rad), washed with 20 column volumes of buffer A
containing 20 mM imidazole, and eluted with buffer A (pH
7.0) containing 250 mM imidazole (all at 4 °C). The purified
protein was used immediately for reconstitution.
Reconstitution of LmrA into Liposomes. E. coli total lipid
extract (Avanti Polar Lipids) was washed with an acetone/
ether mixture (18), dried, and resuspended in 50 mM Hepes-
KOH (pH 7.2) at a concentration of 20 mg/mL. The
suspension was frozen in liquid nitrogen, slowly thawed at
room temperature, and sonicated on ice using a tip sonicator
at an intensity of 4 ím (peak to peak) for four cycles of
sonication for 15 s and resting for 45 s. Aliquots of 2 mL
were frozen in liquid nitrogen and slowly thawed at room
temperature. This freeze-thaw step was repeated once, and
aliquots of the liposome suspension were frozen in liquid
nitrogen and stored at -80 °C. To obtain unilamellar
liposomes with a relatively homogeneous size, the frozen
liposome suspension was slowly thawed at room temperature
and extruded 11 times through a 400 nm polycarbonate filter.
After dilution to 4 mg of lipid/mL, liposomes were saturated
with DDM and solubilization was monitored at OD450 as
described by Paternostre et al. (19). Purified LmrA was
mixed with DDM-saturated liposomes (1 ímol of DDM/
mg of lipid) at a 1/20 ratio (w/w) and incubated for 30 min
at room temperature under gentle agitation. The detergent
was removed by two successive extractions with polystyrene
beads (Bio-Beads SM-2, Bio-Rad, extensively washed with
methanol, ethanol, and water), first at a wet weight of 80
mg/mL of liposome suspension for2ha troom temperature
and then at a wet weight of 160 mg/mL of liposome
suspension overnight at 4 °C, under gentle agitation. The
proteoliposomes were harvested by centrifugation (280000g
for 30 min at 4 °C), resuspended in 50 mM Hepes-KOH
(pH 7.4) at a final concentration of 1 mg/mL, frozen in liquid
nitrogen, and stored at -80 °C.
ATPase Assay. The ATPase activity of reconstituted LmrA
was determined using the colorimetric assay of Lanzetta et
al. (20). Proteoliposomes were incubated at 30 °C in a buffer
containing 50 mM Tris-HCl (pH 7.5), 150 mM NH4Cl, 5
mM MgSO4, 15 mM MgCl2, and 1 mM ATP. At regular
time intervals, samples of 30 íL were transferred to a 96-
well microplate and 150 íL of malachite green molybdate
reagent was added. After 5 min, 34% citric acid was added.
Absorbance at 600 nm was measured after incubation for
50 min at room temperature and compared with that of a
phosphorus standard.
Hoechst 33342 Transport Assays. The transport activity
of LmrA and LmrCD was assayed by means of the drug
Hoechst 33342 [2¢-(4-ethoxyphenyl)-5-(4-methyl-1-piper-
azinyl)-2,5¢-bi-1H-benzimidazole, Molecular Probes] (11,
12).
Table 1: L. lactis Plasmids
plasmid relevant characteristics ref
pNHLmrA pNZ8048 harboring the lmrA gene with upstream regions encoding an N-terminal
six-histidine tag and an enterokinase cleavage site
11
pHLA490A pNHLmrA encoding the G490A ATPase mutant of LmrA this study
pHLA512Q pNHLmrA encoding the E512Q ATPase mutant of LmrA this study
pNSGA pNZ8048 harboring the LmrCD gene with a downstream region encoding a Streptag II 12
control vector pNZ8048 expression vector carrying the inducible PnisA,C m r 15
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of protein/mL) were suspended in 50 mM Hepes-KOH (pH
7.4) containing 2 mM MgSO4, 8.5 mM NaCl, 5 mM
phosphocreatine, and 0.1 mg/mL creatine kinase. After
incubation for 1 min at 30 °C, 0.5 íM Hoechst 33342 was
added. Once the signal was stable, 2 mM Mg2+-ATP was
added and the Hoechst 33342 fluorescence was recorded over
time.
Cells. L. lactis NZ9000 ¢lmrA cells harboring pNZ8048-
based expression or control vectors were grown at 30 °Ct o
an OD660 of 0.6-0.8, whereupon 0.5 ng/mL Nisin A was
added. Growth was continued for a further 90 min. The cells
were harvested and resuspended in 50 mM potassium
phosphate (pH 7.0) containing 5 mM MgSO4. Dinitrophenol
was added to 0.5 mM, and the cells were incubated for 30
min at 30 °C. The cells were washed four times with 50
mM potassium phosphate (pH 7.0) containing 5 mM MgSO4,
resuspended in the same buffer to an OD660 of 5, and kept
on ice. For the actual experiment, the cells were diluted to
an OD660 of 0.5 in the same buffer at 30 °C. Hoechst 33342
was added to a concentration of 0.5 íM.
All measurements were performed with a PerkinElmer Life
Sciences model 50B fluorometer with a magnetic stirred
holder at 30 °C using emission and excitation wavelengths
of 355 and 457 nm, respectively.
pH Dependence of Hoechst 33342 Fluorescence. Extruded
liposomes (20 íL) in 50 mM Hepes-KOH (pH 7.2) at a
concentration of 20 mg/mL were diluted in 2 mL of a buffer
with an appropriate pH [50 mM Bis-Tris for pH 5.2, 6.0,
and 6.5 and 50 mM Hepes-KOH for pH 7.0, 7.5, and 7.8],
and then 1 íM nigericin and 1 íM Hoechst 33342 were
added. For comparison, Hoechst 33342 fluorescence mea-
surements were performed in the absence of liposomes. All
data were acquired with a PerkinElmer Life Sciences model
50B fluorometer with a magnetic stirred holder at 20 °C using
emission and excitation wavelengths of 355 and 457 nm,
respectively.
Hoechst 33342 Resistance Assay. To biologically monitor
the activity of the MDR transporters, the growth rates of L.
lactis NZ9000 ¢lmrA ¢lmrCD cells overexpressing LmrA,
LmrCD, or the empty vector control in the presence of
various concentrations of Hoechst 33342 were recorded.
Overnight cultures were diluted 20 times into fresh medium
and grown for 1 h. Expression was induced by addition of
0.1 ng/mL Nisin A, and cells were grown for an additional
hour. The induced cells were diluted to an OD660 of 0.05,
and 150 íL aliquots were transferred to a 96-well microplate
containing 50 íL of various concentrations of Hoechst 33342
in growth medium containing 0.1 ng/mL Nisin A. Silicon
oil (50 íL) was placed on top of the samples to prevent
evaporation. Cells were grown at 30 °C, and the cell density
was monitored by measuring the OD660 every 6 min for 10
h in a microplate reader (Molecular Devices, Thermomax).
RESULTS
Construction, Expression, and ATPase ActiVity of LmrA
Mutants. To study the self-association of the LmrA dimer
and the presumed cooperativity between the nucleotide
binding domains (NBD), two conserved amino acids that are
critical for ATP hydrolysis were replaced by site-directed
mutagenesis. This concerned substitution of the glycine at
position 490 in the ABC signature motif with an alanine,
and replacement of the glutamic acid at position 512, the
putative catalytic base in the ATPase reaction, with glutamine.
These residues have been shown to be critical in other ABC
transporters, and their mutagenesis normally results in an
abolishment of both the ATPase and transport activity (21-
23). The individual mutants (G490A and E512Q LmrA) were
overexpressed with an N-terminal His tag, purified to
homogeneity, and reconstituted into proteoliposomes com-
posed of E. coli lipids. The ATPase activity of LmrA and
the two mutants was determined by monitoring the release
of inorganic phosphate. The ATPase activity of both mutants
was less than 3% of that observed for wild-type LmrA
(Figure 1), demonstrating that the mutations in the conserved
NBD motifs inactivate the LmrA ATPase activity.
Hoechst 33342 Transport ActiVity of LmrA ATPase
Mutants. To determine if the inactivation of the ATPase
activity of LmrA also interferes with the ATP-dependent
expulsion of drugs, the transport of Hoechst 33342 was
examined. Hoechst 33342 is a substrate for LmrA (11, 24,
25) and many other MDR transporters (e.g., refs 6 and 9).
Transport of this compound in inside-out membrane vesicles
can be readily monitored by its fluorescence properties. In
aqueous solution, Hoechst 33342 is essentially nonfluores-
cent, whereas partitioning into the membrane results in a
significant increase in the fluorescence (2). Addition of
Hoechst 33342 to L. lactis membrane vesicles indeed results
in a marked increase in fluorescence (Figure 2). Upon
addition of ATP, membrane vesicles harboring elevated
levels of wild-type LmrA showed a high Hoechst 33342
transport activity as evidenced by a rapid fluorescence
quenching (Figure 2A). In contrast, ¢LmrA membranes
show only a very small level of fluorescence quenching.
Surprisingly, membranes bearing the inactive G490A and
E512Q ATPase mutants of LmrA showed a remarkably high
level of ATP-dependent quenching of Hoechst 33342
fluorescence (Figure 2A). Whereas the transport activity of
the G490A LmrA mutant was indistinguishable from that
of wild-type LrmA, the activity of the E512Q LmrA mutant
was partially impaired.
FIGURE 1: ATPase activity of reconstituted LmrA. The basal
ATPase activity of LmrA (1), G490A mutant LmrA (2), and E512Q
mutant LmrA (3) was determined by monitoring the release of
inorganic phosphate over time. The ATPase activity of LmrA was
also recorded in the presence of 0.1 mM orthovanadate (4) or 10
mM DCCD (5).
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port ActiVity of LmrA. Vanadate (orthovanadate, VO4
3-)i s
an inhibitor of several ATPase enzymes, including P-gp (26)
and other ABC transporters (27, 28). The ATPase activity
of LmrA is also inhibited by vanadate (Figure 1). At 0.1
mM vanadate, less than 3% of the ATPase activity remained.
Next, the effect of vanadate on LmrA-mediated Hoechst
33342 transport was assayed in membrane vesicles. At a
concentration of vanadate that nearly completely abolished
the ATPase activity of LmrA, essentially no effect was
observed on the transport of Hoechst 33342 when ATP was
added to the membrane vesicles (data not shown).
Effect of Ionophores on the Hoechst 33342 Transport
ActiVity of LmrA. In the inside-out membrane system, ATP
drives not only the LmrA-dependent transport of drugs but
also proton influx by the H+-translocating F0F1-ATPase,
resulting in the generation of a proton motive force (pmf),
inside acidic and positive. Since LmrA is an ATP-dependent
transporter, its activity is not expected to be influenced by
dissipation of the pmf by ionophores. Nigericin is an
ionophore that mediates the electroneutral exchange of K+
for H+, thereby collapsing the transmembrane pH gradient
in these membrane vesicles. Addition of this ionophore
completely reversed the LmrA-dependent Hoechst 33342
transport activity (Figure 2A). When nigericin was included
in the assay before transport was initiated by the addition of
ATP, only a low residual Hoechst 33342 transport activity
was observed (Figure 2A). Addition of the ionophore
valinomycin, which mediates electrogenic K+ movements,
thereby collapsing the transmembrane electrical potential, had
no effect. Transport of Hoechst 33342 by the two LmrA
ATPase mutants was also completely inhibited by nigericin.
An alternative explanation for the nigericin sensitivity of the
Hoechst 33342 transport activity of LmrA is that this
ionophore is a substrate of the transporter. It may compete
with Hoechst 33342 for binding and transport and thereby
block the transport. This hypothesis, however, then assumes
that LmrA discriminates between nigericin and valinomycin,
another peptide ionophore that has no effect on Hoechst
33342 transport. For that reason, we also used an alternative
means to dissipate the ¢pH, employing the weak base
methylammonium. Addition of 25 mM methylammonium
completely reversed the LmrA-dependent Hoechst 33342
transport activity (Figure 2B). Taken together, these data
suggest that LmrA-dependent Hoechst 33342 transport in
membrane vesicles is dependent on the transmembrane pH
gradient.
Hoechst Transport ActiVity of LmrCD. We have recently
described another MDR transporter of L. lactis termed LmrC
and LmrD (12b). These are ABC half-transporters that
constitute a functional heterodimeric ABC-type MDR trans-
porter. In membrane vesicles, LmrCD shows a high ATP-
dependent transport activity of Hoechst 33342 (12b) (Figure
2C). In contrast to the LmrA-dependent activity, transport
of Hoechst 33342 by LmrCD was only marginally affected
by the ionophore nigericin and strongly inhibited by ortho-
vandate (Figure 2C). Likewise, we generated ATPase
mutants of LmrC and LmrD, D495N and E587Q, respec-
FIGURE 2: Hoechst 33342 transport in inside-out membrane vesicles prepared from control-, LmrA-, and LmrCD-expressing cells. Hoechst
33342 was added (H) to inside-out membrane vesicles, and transport was initiated by the addition of 2 mM Mg2+-ATP (ATP). (A) Inside-
out membrane vesicles prepared from cells expressing G490A LmrA (1), LmrA (2), and E512Q LmrA (3) or control cells (4). Experiments
were performed in the presence of 1 íM valinomycin. As indicated, at the end of the experiment, 2 íM nigericin was added. When
nigericin was included in the assay before transport was initiated by the addition of ATP, only a low residual Hoechst 33342 transport
activity was observed (5). For clarity, only the trace for inside-out membrane vesicles prepared from cells expressing E512Q mutant LmrA
is shown. (B) Inside-out membrane vesicles prepared from cells expressing LmrA (1) or from control cells (2). As indicated, 25 mM
methylammonium chloride was added. (C) Inside-out membrane vesicles prepared from LmrCD-expressing (1-4) or control (5) cells.
Transport was assayed under standard conditions (1), and in the presence of 1 íM valinomycin (2), 1 íM nigericin (3), or 0.1 mM
orthovanadate (4). (D) Inside-out membrane vesicles prepared from cells expressing wild-type LmrCD (1), double ATPase mutants of
LmrC and LmrD, D495N and E587Q, respectively (2), and control cells (3).
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mutant LmrCD proteins were expressed, no Hoechst 33342
transport activity was observed (Figure 2D). This shows that
LmrCD functions as a typical ATP-dependent MDR trans-
porter, whereas the Hoechst 33342 transport activity observed
with LmrA is apparently dependent on the pH gradient.
Effect of F0F1-ATPase Inhibition on the LmrA-Dependent
Hoechst 33342 Transport in Membrane Vesicles. Since
proton motive force generation in membrane vesicles in the
presence of ATP requires the activity of the F0F1-ATPase,
we next tested the effect of N,N¢-dicyclohexylcarbodiimide
(DCCD), an effective inhibitor of the H+ translocation
activity of the F0 domain (29). The ATPase activity of
purified LmrA was not affected by 10 mM DCCD (Figure
1). However, treatment of the membrane vesicles with 10
mM DCCD completely abolished the ATP-dependent Ho-
echst 33342 transport activity of LmrA (Figure 3). Taken
together, these data strongly suggest that LmrA-mediated
transport of Hoechst 33342 is not dependent on the LmrA
ATPase activity, but that it is mediated through the trans-
membrane pH gradient which in the membrane vesicles is
generated by the F0F1-ATPase.
pH-Dependent Fluorescence of Hoechst 33342 in Lipid
Vesicles. Acidification of the lumen of the membrane vesicles
by the activity of F0F1-ATPase may influence the Hoechst
33342 fluorescence in the transport assay. To determine the
influence of the pH on the fluorescence of Hoechst 33342,
we have analyzed Hoechst 33342 fluorescence in buffers with
different pH values, both in the absence and in the presence
of liposomes. Hoechst 33342 has a complex, pH-dependent
spectrum, and when the dye is dissolved in a buffer, the
fluorescence quantum yield is much higher at pH 5.0 than
at pH 8.0 (Figure 4, dotted line) (30). When liposomes are
added to the Hoechst solution, the fluorescence increases by
at least 2 orders of magnitudes. However, now an inverted
pH dependence of the fluorescence is observed (Figure 4,
solid line). The pH dependence of the dye fluorescence in
aqueous solution suggests that the compound undergoes
protonation and/or deprotonation of the nitrogen atoms in
the piperazinyl and benzimidazole rings. Although our
experiments do not directly assess partitioning, the increase
in Hoechst 33342 fluorescence with an increase in pH in
the presence of membranes is most likely caused by a more
efficient partitioning of deprotonated and less charged
Hoechst 33342 into the lipid membrane.
Transport of Hoechst 33342 in Intact Cells. The Hoechst
33342 transport assay in membrane vesicles essentially
monitors repartitioning of Hoechst 33342 from the membrane
to the aqueous phase. This assay does not reveal the direction
of transport per se; i.e., the Hoechst 33342 may either be
transported into the lumen of the vesicles or be expelled into
the suspending medium. In cells, Hoechst 33342 becomes
highly fluorescent when it intercalates with the DNA. This
feature can be used to monitor Hoechst 33342 transport in
intact cells as excretion should result in a shift of the
equilibrium from the DNA to the free, soluble state of
Hoechst 33342. In energy-depleted cells of L. lactis bearing
overexpressed levels of LmrA, a rapid influx of Hoechst
33342 was observed (Figure 5) that was barely distinguish-
able from the influx of Hoechst 33342 into control cells.
When cells were energized with glucose, we reproducibly
observed that the Hoechst 33342 influx into cells overex-
pressing LmrA occurred with a faster rate than in control
cells. These data unequivocally show that LmrA does not
expel Hoechst 33342 from the cells. Rather, its presence
causes a slight but reproducible increase in the rate of influx
of Hoechst 33342 into the cell. Since we have previously
shown that under these conditions LmrCD mediates the
FIGURE 3: Effect of DCCD on LmrA-mediated Hoechst 33342
transport in membrane vesicles. Hoechst 33342 was added (H) to
inside-out membrane vesicles prepared from control cells (2 and
3) or LmrA-expressing cells (1 and 4) that were treated with DCCD
(3 and 4) or mock-treated (1 and 2). The system was energized by
the addition of 2 mM Mg2+-ATP (ATP).
FIGURE 4: pH dependence of the Hoechst 33342 fluorescence. The
fluorescence of free Hoechst 33342 (1 íM) in buffer (1, scale on
the right axis) and in the presence of 0.2 mg/mL liposomes and 1
íM nigericin (b, scale on the left axis). a.u. means arbitrary units.
The data points represent the average of 30 s readings recorded
after stabilization of the fluorescence signal of Hoechst 33342.
FIGURE 5: Influx of Hoechst 33342 in cells overexpressing LmrA.
Influx of Hoechst 33342 into washed, energy-deprived cells
expressing LmrA [4, re-energized with 25 mM glucose for 3 min
(2)] or control cells [3, re-energized with 25 mM glucose for 3
min (1)] was assayed in time. Hoechst 33342 (H) was added to a
final concentration of 0.5 íM.
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LmrA exhibits an aberrant behavior of allowing faster influx
of Hoechst 33342 into the cells rather than expelling this
compound.
Hoechst 33342 Resistance of Cells OVerexpressing LmrA
or LmrCD. Hoechst 33342 transport in intact cells was
further studied in a cytotoxicity assay. For this assay, we
used a strain that lacks both LmrA and LmrCD, i.e., L. lactis
NZ9000 ¢lmrA ¢lmrCD. This strain is like the individual
¢lmrCD strain that is hypersensitive to Hoechst 33342 and
other drugs (12a). Unlike the parental strain, L. lactis NZ9000
¢lmrA ¢lmrCD is readily killed by low concentrations of
Hoechst 33342. LmrA or LmrCD was expressed, and the
Hoechst 33342 resistance of the cells was compared with
that of control cells that were transformed with the empty
vector. Expression of LmrA and LmrCD was confirmed by
Western blotting (data not shown). Figure 6 shows the growth
rate as a function of the Hoechst 33342 concentration. The
growth rates of cells expressing LmrCD are similar to those
of the parental L. lactis NZ9000 cells harboring the empty
vector, showing that expression of LmrCD in the (triple)
deletion mutant completely rescues the hypersensitive phe-
notype of the cells toward Hoechst 33342. No protection
was observed when LmrA was expressed. Rather, we
reproducibly found cells to be more sensitive to the drug in
the presence of LmrA. Moreover, the individual L. lactis
NZ9000 ¢lmrA strain (14) exhibited a Hoechst 33342
resistance similar to that of the parental strain (data not
shown). Taken together, these data demonstrate that unlike
LmrCD, LmrA does not protect cells against the cytotoxic
effects of Hoechst 33342.
DISCUSSION
Hoechst 33342 is an organic cation that is used to stain
chromosomal DNA in live cells. It has also been used
extensively to characterize the multidrug transporters in
mammalian cells (2-5) and bacteria (6-12). Hoechst 33342
is strongly fluorescent in the hydrophobic environment of
the membrane, or when intercalated with DNA. However,
it is virtually nonfluorescent in aqueous solution. Because
of this property, Hoechst 33342 is a very useful compound
in studying the transport activity of MDR transporters which
extrude substrates from the cellular membrane into the
external medium. We have compared the Hoechst 33342
transport activity of two bacterial ABC-type MDR transport-
ers, i.e., LmrA of L. lactis which is both structurally and
functionally a homologue of P-gp (24, 31) and LmrCD of
L. lactis, a recently identified heterodimeric ABC transporter
that is highly active in drug excretion (12b). Both systems
are ABC transporters, and their activity is therefore expected
to be dependent on hydrolysis of ATP. Both have been
shown to transport Hoechst 33342 in a membrane vesicle
system in an ATP-dependent manner. However, here we
report that the Hoechst 33342 transport associated with LmrA
in membrane vesicles does not require the ATPase activity
of LmrA itself. Rather, it involves ATP hydrolysis by the
F0F1-ATPase which generates a transmembrane pH gradient
which in turn affects the membrane partitioning and/or the
fluorescence properties of Hoechst 33342 that enters the
membrane vesicles via LmrA. Hoechst 33342 transport is,
however, LmrA-dependent as it is not observed with control
membrane vesicles. Moreover, an extensive study to obtain
structural information about LmrA using a cysteine scanning
approach (25) shows that transmembrane segment 6 (TMS
6) of LmrA is particularly sensitive to mutations that interfere
with Hoechst 33342 transport. Verapamil, a calcium-channel
blocker, is also known as an inhibitor of transport of Hoechst
33342 by LmrA (11, 24). In four of the mutants, the extent
of inhibition of Hoechst 33342 transport by verapamil is also
reduced, indicating that these residues are involved in both
Hoechst 33342 transport and binding of verapamil. Finally,
a study using a set of substrate photoaffinity ligands to
identify the substrate-binding domain of LmrA confirms that
TMS 6 is involved in substrate binding (32). Taken together,
these data indicate that Hoechst 33342 moves via the
substrate binding domain of LmrA.
Several lines of evidence indicate that ATP hydrolysis by
LmrA is not needed for LmrA-mediated Hoechst 33342
transport in membrane vesicles. First, mutagenesis of the
conserved and functionally critical residues of the nucleotide
binding domain of LmrA that abolishes its ATPase activity
has no or little effect on Hoechst 33342 transport in
membrane vesicles. Second, vanadate, a potent inhibitor of
the LmrA ATPase activity, has no effect on Hoechst 33342
transport in membranes. In a previous study (11), vanadate-
sensitive Hoechst 33342 transport by LmrA was seen in
proteoliposomes. However, the observed transport activity
in proteoliposomes was extremely low compared to that in
membrane vesicles. We have not been able to detect any
significant difference in LmrA proteoliposomes with the
Hoechst 33342 transport assay when comparing addition of
ATP with that of the nonhydrolyzable ATP analogue AMP-
PNP (unpublished results). Third, LmrA-mediated Hoechst
33342 transport in membrane vesicles is completely inhibited
by nigericin, an ionophore that acts as a H+/K+ antiporter,
and by the weak base methylammonium. Both of these
compounds collapse the transmembrane pH gradient in
membrane vesicles. In contrast, Hoechst 33342 transport was
not inhibited by another peptide ionophore valinomycin,
suggesting that it is mostly, if not exclusively, dependent
on the transmembrane pH gradient. The alternative explana-
tion that nigericin is a substrate of LmrA and thus competes
with Hoechst 33342 for binding and transport by LmrA
cannot be ruled out, but this possibility seems unlikely as
FIGURE 6: LmrA does not provide cellular resistance to Hoechst
33342. L. lactis NZ9000 ¢lmrA ¢lmrCD cells expressing LmrA
(1) or LmrCD (3) or control cells harboring the empty vector (2)
or the parental strain L. lactis NZ9000 harboring the empty vector
(4) were grown in the presence of different concentrations of
Hoechst 33342. The growth rate (í) in the exponential growth phase
was determined and plotted as a function of the Hoechst 33342
concentration. The data are the average of three experiments. The
error bars indicate the standard deviation.
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nium. Fourth, LmrA-mediated Hoechst 33342 transport is
blocked by DCCD, whereas its ATPase activity is unaffected.
DCCD is an efficient inhibitor of the F0F1-ATPase. The latter
enzyme is solely responsible for the generation of a proton
motive force in membrane vesicles of L. lactis. For com-
parison, similar experiments were conducted with membrane
vesicles bearing elevated levels of the ABC-type MDR
transporter LmrCD. Like LmrA, LmrCD mediates Hoechst
33342 transport in membrane vesicles. However, this trans-
port reaction is strictly dependent on ATP hydrolysis by
LmrCD as it is inhibited by nucleotide binding site mutations
that block the ATPase activity. Transport is strongly inhibited
by vanadate, but barely affected by nigericin. Taken together,
these data strongly suggest that ¢pH-dependent Hoechst
33342 transport is a reaction that is specific for LmrA as
Hoechst 33342 transport via the analogous LmrCD system
is not influenced by the proton motive force.
It is generally believed that the Hoechst 33342 transport
assay in membrane vesicles records the MDR transporter-
dependent repartitioning of Hoechst 33342 from the mem-
brane phase into the aqueous solution. It is important to stress
that these experiments do not reveal whether Hoechst 33342
is released inside of the lumen of the inside-out vesicles or
into the external solution, although transport into the vesicles
would be the expected physiological direction of transport.
To determine the physiological direction of transport, experi-
ments were carried out with intact cells. In this case, the
Hoechst 33342 fluorescence mostly originates from the
intercalation of Hoechst 33342 with DNA inside the cell.
MDR transport activity in intact cells that is associated with
drug extrusion will prevent entry of Hoechst 33342 into the
cell. Indeed, this is the case with glucose-energized cells
bearing elevated levels of LmrCD (12b). In contrast, glucose-
energized cells bearing elevated levels of LmrA were unable
to prevent the entry of Hoechst 33342. This experiment
demonstrates that LmrA does not mediate Hoechst 33342
extrusion; rather, LmrA highly reproducibly permits a slightly
higher rate of influx of Hoechst 33342 into the cells as
compared to the control. Also in the cytotoxicity tests, LmrA
provided no protection against Hoechst 33342 and even
makes cells more susceptible to Hoechst 33342. In contrast,
expression of LmrCD rendered cells less sensitive to Hoechst
33342. Taken together, these data indicate that LmrA does
not seem to function as a true multiple-drug transporter for
Hoechst 33342. This appears to be different with other
substrates. For instance, N-ethylmaleimide (NEM) labeling
of a cysteine mutant of the glycine at position 386 in the
Walker A region of the NBD of LmrA completely inhibited
the LmrA-dependent fluorescent phospholipid transbilayer
movement in proteoliposomes (33). It is interesting to note
that Hoechst 33342 transport in inside-out membrane vesicles
bearing the same mutant of LmrA is not sensitive to NEM
(G. J. Poelarends, unpublished data). It is, however, unclear
how different substrates, i.e., Hoechst 33342 and fluorescent
phospholipids, can be transported by different mechanisms
by LmrA.
As discussed above, our data strongly suggest that LmrA
mediates cellular entry of Hoechst 33342. One major caveat
of this kind of analysis is that the levels of LmrA upon
overexpression can be as high as 30% of the total membrane
protein (11). When the expression levels of LmrA are
reduced, the Hoechst 33342 transport activity in vesicles can
no longer be detected. At this stage, we cannot exclude the
possibility that the Hoechst 33342 transport activity of LmrA
is due to the large amounts of membrane protein, but it
should be stressed that all drug extrusion tests reported to
date were performed under overexpressing conditions and
that LmrA mutants have been described that exhibit a
reduced Hoechst 33342 transport activity (25). One may
argue that LmrA forms a kind of channel in the membrane
that allows facilitated influx of Hoechst 33342. Our experi-
ments with the pH dependence of the Hoechst 33342
fluorescence in the presence of liposomes indicate that the
transport activity in membrane vesicles is due to a pH-
dependent partitioning of Hoechst 33342 between the
membrane and water phase or, alternatively, a pH depen-
dence of the fluorescence of the membrane-inserted Hoechst
33342. We consider the pH-dependent partitioning model,
however, more likely. In solution, Hoechst 33342 exhibits a
low fluorescence that was even further reduced with an
increase in pH. In the presence of liposomes, a marked
increase in fluorescence is observed but the pH dependence
of the fluorescence now shows a reversed pH profile; i.e.,
the fluorescence increases with pH. This phenomenon is
likely due to a more efficient partitioning of the deprotonated
and uncharged Hoechst 33342 into lipids. In membrane
vesicles, the generation of a transmembrane pH gradient by
the F0F1-ATPase results in an acidic pH inside. This low
pH will favor a repartitioning of Hoechst 33342 from the
membrane phase into the acidic aqueous phase of the lumen
of the vesicles, thus causing a lowering of the dye fluores-
cence. Since this activity is dependent on LmrA, it seems
that LmrA accelerates the movement of Hoechst 33342 from
the membrane phase to the aqueous phase. Importantly, with
intact cells, LmrA is unable to excrete Hoechst 33342 from
the cells, and its presence even increases the cytotoxicity of
Hoechst 33342 in L. lactis cells. This strongly suggests that
LmrA facilitates the transmembrane movement of Hoechst
33342. It is unclear if this activity relates to peculiar H+/
drug symport reaction that was suggested recently for the
separately expressed transmembrane domain of LmrA (LmrA-
MD) (34), as our study involved only the full-length LmrA.
In contrast to the growth studies reported by Venter et al.
(34), who used a wild-type L. lactis strain, our study employs
a triple knockout strain which lacks LmrA, LmrC, and LmrD.
Therefore, the results of the growth inhibition studies cannot
be directly compared as the triple deletion strain is much
more susceptible to Hoechst 33342. It is difficult to envisage
how the proton-linked activity of LmrA would contribute to
its proposed physiological function as a drug efflux system.
This study raises questions about the physiological sig-
nificance of LmrA as a multiple-drug transporter. Moreover,
a knockout of the lmrA gene in L. lactis has no effect on the
Hoechst 33342 (this paper) and ethidium (12b) sensitivity
of the cells, while inactivation of the lmrCD genes makes
cells highly susceptible to these compounds. Therefore, it
will be important to study the exact role of LmrA in the
native host L. lactis.
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